Mallinckrodt PLC (MNK)

43.18
0.64 1.50
NYSE : Health Care
Prev Close 42.54
Open 42.58
Day Low/High 42.54 / 43.99
52 Wk Low/High 41.57 / 85.83
Volume 2.49M
Avg Volume 2.20M
Exchange NYSE
Shares Outstanding 104.69M
Market Cap 4.61B
EPS 5.80
P/E Ratio 24.07
Div & Yield N.A. (N.A)

Latest News

Short Interest Makes 15.2% Move For MNK

Short Interest Makes 15.2% Move For MNK

The most recent short interest data has been released for the 02/28/2017 settlement date, which shows a 1,763,116 share increase in total short interest for Mallinckrodt plc , to 13,376,918, an increase of 15.18% since 01/31/2017. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

Pharma, Biotech Stocks Fall on Trump Tweets, GOP Health Care Plan

Pharma, Biotech Stocks Fall on Trump Tweets, GOP Health Care Plan

Investors are deciding what to make of an impending overhaul of the American health care system in the wake of legislative progress out of Washington.

INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders It Filed A Complaint To Recover Losses Suffered By Investors In Mallinckrodt Plc -- Lead Plaintiff Deadline Of March 27, 2017

INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders It Filed A Complaint To Recover Losses Suffered By Investors In Mallinckrodt Plc -- Lead Plaintiff Deadline Of March 27, 2017

The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired common stock shares of Mallinckrodt plc ("Mallinckrodt") (NYSE:MNK) between...

Mallinckrodt Plc Board Expands Company's Share Repurchase Plan By $1.0 Billion; Company Announces Results Of 2017 Annual General Meeting

Mallinckrodt Plc Board Expands Company's Share Repurchase Plan By $1.0 Billion; Company Announces Results Of 2017 Annual General Meeting

-- Board and management long-term outlook reflected in share repurchase authorization, reinforces Mallinckrodt's inherent long-term earnings power and free cash generation capabilities --

MNK INVESTORS ALERT: Lieff Cabraser Reminds Investors Of Deadline In Class Action Against Mallinckrodt Plc

MNK INVESTORS ALERT: Lieff Cabraser Reminds Investors Of Deadline In Class Action Against Mallinckrodt Plc

The law firm of Lieff Cabraser Heimann & Bernstein, LLP reminds investors of the upcoming deadline to move for appointment as lead plaintiff in securities class litigation brought on behalf of investors who purchased or...

Mallinckrodt Moves Up In Analyst Rankings, Passing Raytheon

Mallinckrodt Moves Up In Analyst Rankings, Passing Raytheon

In a study of analyst recommendations at the major brokerages, for the underlying components of the S&P 500, Mallinckrodt plc has taken over the #17 spot from Raytheon Co. , according to ETF Channel.

MNK SHAREHOLDER ALERT: The Law Offices Of Vincent Wong Reminds Investors Of A Class Action Involving Mallinckrodt Plc And A Lead Plaintiff Deadline Of March 27, 2017

MNK SHAREHOLDER ALERT: The Law Offices Of Vincent Wong Reminds Investors Of A Class Action Involving Mallinckrodt Plc And A Lead Plaintiff Deadline Of March 27, 2017

The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the District of Columbia on behalf of investors who purchased Mallinckrodt plc (NYSE:MNK) securities between November...

DEADLINE ALERT: Brower Piven Alerts Shareholders Of Approaching Deadline In Class Action Lawsuit And Encourages Those With Losses In Excess Of $100,000 From Investment In Mallinckrodt Public Limited Company To Contact The Firm

DEADLINE ALERT: Brower Piven Alerts Shareholders Of Approaching Deadline In Class Action Lawsuit And Encourages Those With Losses In Excess Of $100,000 From Investment In Mallinckrodt Public Limited Company To Contact The Firm

The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the District of Columbia on behalf of...

Eli Lilly Is Great Stock to Buy Now

Eli Lilly Is Great Stock to Buy Now

Here's why the pharmaceutical company is a solid addition to your portfolio.

MNK INVESTORS ALERT: Lieff Cabraser Announces Securities Class Action Against Mallinckrodt Plc

MNK INVESTORS ALERT: Lieff Cabraser Announces Securities Class Action Against Mallinckrodt Plc

The law firm of Lieff Cabraser Heimann & Bernstein, LLP announces that class action litigation has been filed on behalf of investors who purchased or otherwise acquired the securities of Mallinckrodt plc...

MNK LOSS NOTICE: Rosen Law Firm Reminds Mallinckrodt Public Limited Company Investors Of Important Deadline In Class Action

MNK LOSS NOTICE: Rosen Law Firm Reminds Mallinckrodt Public Limited Company Investors Of Important Deadline In Class Action

Rosen Law Firm, a global investor rights law firm, reminds purchasers of Mallinckrodt Public Limited Company securities (NYSE: MNK) from November 25, 2014 through January 18, 2017, inclusive (the "Class Period") of the...

INVESTOR ALERT: Brower Piven Encourages Shareholders Who Have Losses In Excess Of $100,000 From Investment In Mallinckrodt Public Limited Company To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit

INVESTOR ALERT: Brower Piven Encourages Shareholders Who Have Losses In Excess Of $100,000 From Investment In Mallinckrodt Public Limited Company To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit

The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the District of Columbia on behalf of...

Deals, Bargain Price Make Mallinckrodt a Good Pharma Buy

Deals, Bargain Price Make Mallinckrodt a Good Pharma Buy

This British company is also working harder to develop its drug pipeline.

Mallinckrodt Divests Drug Delivery Unit as Shedding Continues

Mallinckrodt Divests Drug Delivery Unit as Shedding Continues

The pharmaceutical company has signed a deal to sell its intrathecal therapy segment to a Piramal Enterprises subsidiary for up to $203 million.

Mallinckrodt Completes Sale Of Its Nuclear Imaging Business To IBA Molecular For Approximately $690 Million

Mallinckrodt Completes Sale Of Its Nuclear Imaging Business To IBA Molecular For Approximately $690 Million

-- Transaction advances Mallinckrodt's strategic portfolio transformation to specialty pharmaceuticals; benefits patients around the world who rely on medical isotopes --

Mallinckrodt Becomes #95 Most Shorted S&P 500 Component, Replacing HCA Holdings

Mallinckrodt Becomes #95 Most Shorted S&P 500 Component, Replacing HCA Holdings

The most recent short interest data has been released for the 01/13/2017 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the S&P 500 by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.

SHAREHOLDER ALERT: Goldberg Law PC Announces Securities Class Action Lawsuit Against Mallinckrodt PLC And Encourages Investors With Losses To Contact The Firm

SHAREHOLDER ALERT: Goldberg Law PC Announces Securities Class Action Lawsuit Against Mallinckrodt PLC And Encourages Investors With Losses To Contact The Firm

Goldberg Law PC, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Mallinckrodt PLC ("Mallinckrodt" or the "Company") (NYSE: MNK).

EQUITY ALERT: Rosen Law Firm Announces Filing Of Securities Class Action Lawsuit Against Mallinckrodt Plc

EQUITY ALERT: Rosen Law Firm Announces Filing Of Securities Class Action Lawsuit Against Mallinckrodt Plc

Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of Mallinckrodt plc securities (NYSE:MNK) from November 25, 2014 through January 18, 2017, inclusive...